Cambridge Investment Research Advisors Inc. Has $32.06 Million Stock Holdings in Strategy Incorporated (NASDAQ:MSTR)

Cambridge Investment Research Advisors Inc. boosted its stake in shares of Strategy Incorporated (NASDAQ:MSTR - Free Report) by 1.0% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 110,686 shares of the software maker's stock after buying an additional 1,125 shares during the period. Cambridge Investment Research Advisors Inc.'s holdings in Strategy were worth $32,057,000 as of its most recent filing with the SEC.

Several other large investors also recently made changes to their positions in the stock. Franklin Resources Inc. lifted its holdings in shares of Strategy by 3.3% in the third quarter. Franklin Resources Inc. now owns 4,248 shares of the software maker's stock valued at $716,000 after purchasing an additional 135 shares in the last quarter. B. Riley Wealth Advisors Inc. acquired a new position in Strategy during the third quarter worth $254,000. Versant Capital Management Inc grew its position in Strategy by 38.2% in the fourth quarter. Versant Capital Management Inc now owns 141 shares of the software maker's stock valued at $41,000 after purchasing an additional 39 shares in the last quarter. GAMMA Investing LLC increased its stake in Strategy by 56.5% in the 4th quarter. GAMMA Investing LLC now owns 562 shares of the software maker's stock valued at $163,000 after buying an additional 203 shares during the last quarter. Finally, Nordea Investment Management AB lifted its position in Strategy by 28.9% during the 4th quarter. Nordea Investment Management AB now owns 14,505 shares of the software maker's stock worth $4,395,000 after buying an additional 3,255 shares in the last quarter. Institutional investors own 59.84% of the company's stock.

Insider Buying and Selling at Strategy

In related news, EVP Wei-Ming Shao bought 500 shares of the business's stock in a transaction on Thursday, March 20th. The shares were purchased at an average price of $85.00 per share, for a total transaction of $42,500.00. Following the completion of the transaction, the executive vice president now directly owns 500 shares of the company's stock, valued at approximately $42,500. This represents a ∞ increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, Director Jarrod M. Patten sold 3,100 shares of the company's stock in a transaction on Friday, April 25th. The stock was sold at an average price of $365.33, for a total transaction of $1,132,523.00. Following the transaction, the director now owns 4,970 shares of the company's stock, valued at $1,815,690.10. This trade represents a 38.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have bought 8,000 shares of company stock valued at $680,000 and have sold 37,798 shares valued at $12,535,866. Insiders own 9.16% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on MSTR. Barclays lifted their target price on Strategy from $421.00 to $475.00 and gave the company an "overweight" rating in a research report on Monday. Maxim Group raised their target price on shares of Strategy from $480.00 to $500.00 and gave the company a "buy" rating in a research note on Thursday, February 6th. Canaccord Genuity Group upped their price target on shares of Strategy from $409.00 to $464.00 and gave the stock a "buy" rating in a research report on Friday, May 2nd. HC Wainwright assumed coverage on shares of Strategy in a research report on Tuesday, April 29th. They issued a "buy" rating and a $480.00 price objective for the company. Finally, Compass Point raised shares of Strategy to a "strong-buy" rating in a report on Wednesday, January 29th. One research analyst has rated the stock with a sell rating, ten have assigned a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $514.42.

Strategy Stock Performance

NASDAQ MSTR opened at $385.86 on Wednesday. The firm has a 50-day moving average price of $309.58 and a two-hundred day moving average price of $325.34. Strategy Incorporated has a 12-month low of $102.40 and a 12-month high of $543.00. The company has a market capitalization of $99.30 billion, a P/E ratio of -68.50 and a beta of 3.79. The company has a quick ratio of 0.65, a current ratio of 0.71 and a debt-to-equity ratio of 0.39.

Strategy (NASDAQ:MSTR - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The software maker reported ($16.49) EPS for the quarter, missing analysts' consensus estimates of ($0.02) by ($16.47). Strategy had a negative return on equity of 19.01% and a negative net margin of 251.73%. The company had revenue of $111.07 million for the quarter, compared to the consensus estimate of $116.66 million. During the same quarter last year, the business earned ($0.83) EPS. Strategy's revenue was down 3.6% on a year-over-year basis.

About Strategy

Strategy Incorporated, formerly known as MicroStrategy, provides artificial intelligence-powered enterprise analytics software and services in the United States, Europe, the Middle East, Africa, and internationally. It offers Strategy ONE, a platform that allows non-technical users to access novel and actionable insights for decision-making, and Strategy Cloud for Government, which provides always-on threat monitoring designed to meet the strict technical and regulatory standards of governments and financial institutions.

Want to see what other hedge funds are holding MSTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Strategy Incorporated (NASDAQ:MSTR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.